IMS Health Holdings Inc

IMS Health — Merger or Acquisition (July 2005)

37 slides from IMS Health's merger presentation, Jul 11, 2005

  1. Slide 1: Global Leadership in Market Intelligence

    July 11, 2005

  2. Slide 2: Safe Harbor

    ‘Safe Harbor Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 ‘Thi document contains certain fomarclooking information about IMS Health IncomporatedCIMS'), VNU NV. CVNU') andthe combined company ater completon ofthe transactions that are inended to be covered bythe sa

  3. Slide 3: Transaction Disclosure

    Transaction Disclosure ‘Additional Information and Where to Find Thi documant may be deemed f be soliton mateial in raspedt ofthe proposed manger of IMS and VNU. In connection wih he proposed transaction, VU and MS il fsa regitation statement on Form F-4,incuing the preliminary jcintpronystatemantpr

  4. Slide 4: Strategic Overview

    Strategic Overview Rob van den Bergh Innovation and Execution Integration and Synergies Financial Summary Summary Wvnau David Carlucci Nancy Cooper Rob Ruijter Rob van den Bergh

  5. Slide 5: Global Leadership In Market Intelligence

    Global Leadership In Market Intelligence Wvnau ims The world’s leading marketing information, media measurement and business information company Wvau The world’s leading provider of information and consulting solutions to the pharmaceutical and healthcare industries Global leadership in market intel

  6. Slide 6: Transaction Summary

    Transaction Summary Offer to IMS $28.10 per share ® Shareholders: = $11.25 in cash = 0.60415 VNU share for each IMS share Transaction Value: $6.6 billion (€5.5 billion) equity value; $7.0 billion (€5.8 billion) enterprise value Resulting Ownership: 65% VNU / 35% IMS shareholders Listing: Euronext Am

  7. Slide 7: Capitalizing on Major Trends

    Capitalizing on Major Trends vewend ¢ Clients increasingly demand intelligence, (ee analytics and insights in addition to Insights highest quality data Global Scale Requirement, ¢ Global presence, scale and capabilities Weed te, ¢ Need to understand consumer behavior Understand Consumer continues to

  8. Slide 8: Creating Shareholder Value

    Creating Shareholder Value cs * Adds high growth, highly * Broadens offering capabilities profitable business e Expands and and builds upon Accelerates development of consulting and services consulting and services model offerings ¢ Creates meaningful synergies Facilitates expansion into new ¢ Stren

  9. Slide 9: Transformation of VNU

    Transformation of VNU Over the past seven years, VNU has transformed from a diversified publisher into a leader of market intelligence 1998 Business Mix New Merged Company ‘i Blslere Business leuspapers Hikari Information ace, 229% 499 Healtheare Market Intelligence Educational Publishing 2e% 2% con

  10. Slide 10: Merged Management Team

    Merged Management Team Supervisory Board Executive Board cEO Rob van den Bergh + Business Information + HR + Legal Chief Transformation Officer Deputy CEO and CoO. CFO Nancy Cooper David Carlucci Rob Ruijter Marketing Information + Comorate Controlling . Carat Development * Media Measurement & © Tre

  11. Slide 11: Strategic Overview

    Strategic Overview Rob van den Bergh Innovation and Execution David Carlucci Integration and Synergies Financial Summary Summary Wvnau Nancy Cooper Rob Ruijter Rob van den Bergh

  12. Slide 12: Global Leader in Market Intelligence

    Global Leader in Market Intelligence Marketing Healthcare Media Business Information Market Measurement & Information Intelligence Information + €1.88 ($2.2B)() + €1.38 ($1.6B)() + €0.98 ($1.1B)() + €0.68 ($0.7B)0) + 27,000 employees | | + 6,400 employees | | + 8,800 employees | | + 2,600 employees

  13. Slide 13: Global Clients Trust VNU and IMS

    Global Clients Trust VNU and IMS Cxbila VNU & IMS clients have common business issues Optimizing their return on investment Expanding in the global marketplace Responding to heightened consumer influences Operating in highly competitive environments e TESS cBse@ roger) AvAtrersons ccomeces ims

  14. Slide 14: Overview of IMS

    Overview of IMS ¢ World’s leading provider of market intelligence to the pharmaceutical and healthcare industries ¢ $1.6 billion in revenues for 2004 - Over 60% of revenues outside U.S. e More than 6,000 employees in over 100 countries ¢ Tracks over 1 million brands, daily @ ( m S INTELLIGENCE. APPL

  15. Slide 15: IMS Strategy for Growth

    IMS Strategy fo wth Invest in Data and Anal s Accelerate Growth in Consulting and Services Develop New Markets and Audiences 5 ~~ | [sakes ud ——o—— f beri be oq ._ —

  16. Slide 16: IMS: A Strong Global Franchise

    IMS: A Strong Global Franchise Leadership Po: n * #1 Global Market Position « Strength of Client Base * Global Scale and Coverage Financial Model + Strong Revenue Growth « High Free Cash Flows + High Return on Invested Capital + Strong EBITDA Margins: 33% Reported Revenue Growth ieee 14% - BE 2002 2

  17. Slide 17: Measurement Information

    Mea Informatior nent Consumer Healthcare Media Products Consumer goods |* Prescription and Media ratings — tracking over-the-counter TY, Internet Consumer tracking Advertising behavior and |» Doctor behavior spending attitudes and prescriptions |e Box office Demographics |e Therapeutic class | © Pro

  18. Slide 18: Example: Product Manager of OTC Antihistamine

    Example: Product Manager of OTC Antihistamine VNU: Front of Store IMS: Back of Store « Over-the-counter market + Prescription market share share of antihistamines « Over-the-counter + Prescription promotional spending promotional spending + Consumer impressions + Direct-to-consumer * Demographics ef

  19. Slide 19: Link to searchable text of slide shown above

    Link to searchable text of slide shown above

  20. Slide 20: A Compelling Combination

    A Compelling Combination e Dramatically enhances value to our existing clients e Expands consulting and services e Benefits from common business processes e Creates significant opportunities for new audiences and new markets e Capitalizes on trends in the marketplace Wvau ims

  21. Slide 21: Strategic Overview

    Strategic Overview Innovation and Execution Rob van den Bergh David Carlucci Integration and Synergies Nancy Cooper Financial Summary Summary Wvnau Rob Ruijter Rob van den Bergh

  22. Slide 22: Disciplined Approach to Integration

    Disciplined Approach to Integration Implement a new approach... * Create global processes to improve business performance Assign functional and regional leaders Staff to achieve results Taking advantage of joint experience ...to deliver results Integrating assets across all businesses Build repeatab

  23. Slide 23: Integrating the Businesses

    Integrating the Businesses Common Processes Data can be used across businesses Consulting adds to value propositions Common processes can be utilized ims

  24. Slide 24: Data can be Used Across Businesses

    Data can be Used Across Businesses Market Information & Analysis Consumer Products Healthcare Media Combine Over-the-Counter + Prescription Data Combine Doctor + Consumer Combine Doctor + Consumer Panels + Panels Media Ratings Integrate BASES Forecasting Tool

  25. Slide 25: VNU IMS Consumer Products Healthcare Media

    vnu Consumer Products Healthcare Media ims

  26. Slide 26: Synergy Overview

    Synergy Overview Data Across Businesses Expansion of Consulting & Services €125M Revenue aoe ($150M) Customer Opportunities Geographic Depth Regional €85M Cost Corporate ($100M) IT / Production €110M EBITDA ($130M ) Note! Represent synergias expected be realized by year 3. Wvnau

  27. Slide 27: Strategic Overview

    Strategic Overview Innovation and Execution Integration and Synergies Rob van den Bergh David Carlucci Nancy Cooper Financial Summary Rob Ruijter Summary Wvnau Rob van den Bergh

  28. Slide 28: VNU's Merger with IMS: Consistent with Criteria

    VNU’s Merger with IMS: Consistent with Criteria ¢ Strategic - Bea leader in marketing and media information - Strong strategic fit with existing businesses: non-cyclical, recurring revenue businesses - Focused, high-growth company with leading positions ¢ Financial - Expected to be accretive to cash

  29. Slide 29: 2004 Revenue by Segment

    2004 Revenue by Matting Information Heathcare ‘ Manet Intetigence Europe, Middle Easté, Aiea | Famericas Media Business Entertainment Information Inorm ation €4,680MM ($5,590MM) _ €1,080MM ($1,295MM) EBITDA Margin: 23% Source: VNU based on 2004 VNU annual report (po forma for divestiure of WD); IMS

  30. Slide 30: Transaction Value and Implied Multiples

    Transaction Value and Implied Multiples (Amounts in millions, except per share data) Offer Price per Share Diluted Shares Outstanding Equity Value Net Debt (3/31/05) Minority Interest Transaction Value €5,844 $6,982 Transaction Value / 2005E IMS EBITDA ($560MM - $580MM)? 12.0x - 12.5 Offer Price/200

  31. Slide 31: Financing Plan and Capital Structure

    Financing Plan and Capital Structure Implications ¢ Approximately 60% of consideration in VNU equity; 40% in cash - 136.4 million new VNU shares issued - €2.1 / $2.5 billion total cash consideration to IMS holders ¢ Net Debt at closing of approximately €3.3 billion, or 2.8x 2005E pro forma EBITDA ¢

  32. Slide 32: Financing Plan and Capital Structure

    Financing Plan and Capital Structure Implications (Cont'd) ¢ Stock repurchase program of up to €500 million - Company is targeting to be below 3.0x Net Debt / EBITDA on an ongoing basis ¢ Dividends will be at least equal to existing policy ¢ Reporting in IFRS with U.S. GAAP reconciliation ¢ Trading

  33. Slide 33: Summary of Financial Combination Benefits

    Summary of Financial Combination Benefits e Annual revenue synergies target of at least €125 million ($150 million) by year 3 - Expect approximately 20% weighted average EBITDA margin, or €25 million ($30 million) in EBITDA ¢ Annual cost synergies of at least €85 million ($100 million) by year 3, ap

  34. Slide 34: Estimated Timeline to Completion

    Estimated Timeline to Completion September: - File merger proxy with SEC October — November: - File offering documents with AFM September —- December: - SEC/AFM review period - Hart-Scott-Rodino, EU and other regulatory review period Qi 2006: - Shareholder vote for each of IMS and VNU - Close transa

  35. Slide 35: Strategic Overview

    Strategic Overview Innovation and Execution Integration and Synergies Financial Summary Rob van den Bergh David Carlucci Nancy Cooper Rob Ruijter Summary Rob van den Bergh Wvnau

  36. Slide 36: A Global Leader

    A Global Leader ¢ Leader in market intelligence in three key industries: - Consumer Packaged Goods - Healthcare - Media and Entertainment ¢ Compelling business model ¢ World-class leadership team ¢ Creating shareholder value

  37. Slide 37: Searchable text section of graphics shown above

    Searchable text section of graphics shown above [L OGO] [LOGO] Global Leadership in Market Intelligence Driving Growth through Innovation and Execution [GRAPHIC] [GRAPHIC] [GRAPHIC] July 11, 2005 Sa fe Harbor Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 This docum

IMS Health — Merger or Acquisition (July 2005) on 6ix